Rays Of Belief Reports Q1 Consolidated Net Profit Of 28m Rupees Against YoY Loss

Market snapshot: Rays of Belief Limited (MOMSBELIEF) reported a substantial financial turnaround for the quarter ended June 30, 2026. The company turned profitable, recording a consolidated net profit of ₹2.79 crore against a net loss of ₹53.7 lakh in the same period last fiscal. This turnaround was driven by rapid scaling in international operations and robust operating leverage.

Data Snapshot

• Consolidated revenue from operations surged to ₹25.31 crore in Q1 FY27, compared to ₹10.71 crore in Q1 FY26.
• Consolidated net profit reached ₹2.79 crore in Q1 FY27, reversing a net loss of ₹53.7 lakh in Q1 FY26.
• Consolidated EBITDA rose to ₹5 crore in Q1 FY27 from ₹50 lakh in Q1 FY26, with the EBITDA margin expanding to 19.86% from 4.45%.
• The United States segment revenue contributed ₹12.82 crore, surpassing the domestic India segment revenue of ₹12.49 crore in Q1 FY27.

What's Changed

• Consolidated operations turned highly profitable with a net profit of ₹2.79 crore against a net loss of ₹53.7 lakh in Q1 FY26.
• EBITDA margins expanded by 1,541 bps YoY to reach 19.86% (derived: 19.86% vs 4.45%).
• The United States became the largest geographical segment, contributing 50.65% of total revenue (derived: ₹12.82 crore vs ₹25.31 crore).

Key Takeaways

• The company's asset-light global expansion has started unlocking premium operating leverage.
• A massive 900% growth in EBITDA (derived: ₹5 crore vs ₹50 lakh) demonstrates structured control on operating expenses relative to revenue growth.
• The US market is now the primary revenue driver, contributing over half of the consolidated top-line.

SAHI Perspective

Rays of Belief is demonstrating a textbook model of utilizing India-based clinical and operational expertise to serve high-ticket Western markets. By scaling its personalized intervention plans for children with neurodevelopmental disorders under the 'Mom's Belief' brand, the company has transformed its financial profile. Surpassing Indian domestic revenues with the US segment is a monumental pivot, proving that their global strategy is highly scalable and structurally margin-accretive.

Market Implications

The exceptional turnaround is expected to enhance investor confidence in MOMSBELIEF post-listing. As a highly specialized service provider in the pediatric neurodevelopmental space, the company's strong performance and international scaling make it a unique asset with a lack of direct peers, which could attract institutional interest.

Trading Signals

Market Bias: Bullish

Turnaround to a net profit of ₹2.79 crore from a loss of ₹53.7 lakh YoY, supported by a 136.32% surge in revenue to ₹25.31 crore and a massive margin expansion to 19.86%.

Overweight: Healthcare Services, Pediatric Healthcare

Trigger Factors:

• Sustained quarterly revenues over ₹25 crore.
• Successful integration of the recently acquired US subsidiary, City Pro Group Inc.
• Retention of consolidated EBITDA margins above 15%.

Time Horizon: Medium-term (3-12 months)

Industry Context

The pediatric neurodevelopmental and early intervention market has historically been localized and fragmented. Rays of Belief is pioneering corporate-scale delivery using physical and digital hybrids. Operating through Company Learning Centres and international networks, the company is capturing the massive, high-paying pediatric special education demand in the US while maintaining lower research and operational back-office costs in India.

Key Risks to Watch

• Integration risks related to the newly acquired City Pro Group Inc. in New York.
• Sensitivity to changes in US pediatric early intervention funding and special education regulations.
• Increasing employee benefits expenses as specialized clinical professionals remain core to scaling the business.

Recent Developments

On September 18, 2026, Rays of Belief's wholly owned subsidiary, Mom's Belief US Inc., acquired 100% of City Pro Group Inc., a New York-based pediatric healthcare services provider with an FY25 revenue of US$11.43 million (~₹97.27 crore). Prior to this, the company successfully completed its public listing on the NSE and BSE on September 8, 2026.

Closing Insight

Rays of Belief's high-growth, high-margin model highlights the efficiency of exporting healthcare services to international markets. Reversing losses so rapidly post-listing establishes a strong growth narrative for the company.

High Performance Trading with SAHI.